Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ FATP4/SLC27A4 Recombinant Protein Antigen
SDP

Catalog No. NB398173 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB398173 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB398173 Supplier Novus Biologicals™ Supplier No. NBP305510PEP
Only null left
Add to Cart
Add to Cart

Recombinant Protein

Specifications

For Use With (Application) Antibody Competition
Formulation PBS and 1 M Urea, pH 7.4.
Gene ID (Entrez) 10999
Molecular Weight (g/mol) MolecularWeight-theroretical: 27 kDa
Quantity 100 μL
Storage Requirements Store at -20°C. Avoid freeze/thaw cycles.
Gene Alias ACSVL4Solute carrier family 27 member 4, EC 6.2.1, EC 6.2.1.-, EC 6.2.1.7, FATP-4, FATP4Fatty acid transport protein 4, IPS, long-chain fatty acid transport protein 4, solute carrier family 27 (fatty acid transporter), member 4
Gene Symbol SLC27A4
Conjugate Unconjugated
Species Human
Recombinant Recombinant
Inhibitor Properties This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP3-05510. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/mL
Form Purified
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Protein FATP4/SLC27A4
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.